A recent bioinformatics study which analyzed major datasets including The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Gene Expression Profiling Interactive Analysis (GEPIA) demonstrated poor relapse-free survival and overall survival in breast cancer with higher level of GLUT1 expression [31]. The gene discussed is SLC2A1; the disease is breast carcinoma.